Adhi Karya (Persero) Tbk PT
SWB:KM6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adhi Karya (Persero) Tbk PT
SWB:KM6
|
ID |
|
NervGen Pharma Corp
NASDAQ:NGEN
|
CA |
|
Q
|
Quest Pharmatech Inc
OTC:QPTFF
|
CA |
|
V
|
Valmont Industries Inc
F:VI1
|
US |
|
Genoway SA
F:JEH
|
FR |
|
C
|
Cts Eventim AG & Co KgaA
F:EVD
|
DE |
Wall St Price Targets
KM6 Price Targets Summary
Adhi Karya (Persero) Tbk PT
According to Wall Street analysts, the average 1-year price target for KM6 is 0.004 EUR with a low forecast of 0.003 EUR and a high forecast of 0.004 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KM6's stock price target?
Price Target
0.004
EUR
According to Wall Street analysts, the average 1-year price target for KM6 is 0.004 EUR with a low forecast of 0.003 EUR and a high forecast of 0.004 EUR.
What is the Revenue forecast for Adhi Karya (Persero) Tbk PT?
Projected CAGR
127%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is 127%.
What is the Gross Profit forecast for Adhi Karya (Persero) Tbk PT?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 29%.
What is the Operating Income forecast for Adhi Karya (Persero) Tbk PT?
Projected CAGR
692 639%
Over the last 13 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 1 year is 692 639%.
